Use of Nafamostat Mesilate for Anticoagulation in Patients With ECMO
Use of Nafamostat Mesilate for Anticoagulation in Patients With ECMO
Recruiting · NCT06276010 · Registry updated 2025-09-25Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Use of Nafamostat Mesilate for Anticoagulation in Patients With ECMO | Extracorporeal Membrane Oxygenation Complication | Recruiting | Not applicable | 2025-09-25 | NCT06276010 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Xiaotong Hou | 3 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Beijing Anzhen Hospital | Beijing | China | 23 |